0000000001105426

AUTHOR

Jolly Schmitz

showing 1 related works from this author

Serum microRNA profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal jun…

2014

Neoadjuvant multimodality treatment is frequently applied to improve the poor prognosis of locally advanced adenocarcinomas of the gastroesophageal junction. This study aimed to asses if serum microRNA profiles are useable as response indicators in this therapeutic setting. Fifty patients with locally advanced adenocarcinomas of the gastroesophageal junction were included in the study. All patients received neoadjuvant therapy and subsequently underwent surgical resection. Histomorphologic regression was defined as major histopathological response when resected specimens contained less than 10% vital residual tumor cells. Circulating RNA was isolated from pretherapeutic/post-neoadjuvant blo…

OncologyCancer ResearchPathologymedicine.medical_specialtyMicroarraybusiness.industrymedicine.medical_treatmentRetrospective cohort studyMultimodality TherapyGene expression profilingBlood serumOncologyInternal medicinemicroRNAMedicinebusinessNeoadjuvant therapyChemoradiotherapyInternational Journal of Cancer
researchProduct